Featured on May 2023 Featured Report
More from May 2023 Featured Report
May 21, 2024
May 20, 2024
Q1 2024: Merck KGaA cites volatile CDMO biz and destocking for declined sales
BioNTech: Partnerships are key to deliver drugs at scale
AstraZeneca to build $1.5bn ADC site in Singapore
J&J expands immunotherapy portfolio with $850m Proteologix buy